Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial.
Adult
Contact Tracing
/ statistics & numerical data
Family Characteristics
Female
HIV Infections
/ epidemiology
Humans
Latent Tuberculosis
/ diagnosis
Male
Mycobacterium tuberculosis
/ immunology
Prevalence
Risk Factors
South Africa
/ epidemiology
Tuberculin Test
Tuberculosis, Pulmonary
/ epidemiology
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
10
2019
accepted:
26
02
2020
entrez:
18
3
2020
pubmed:
18
3
2020
medline:
27
6
2020
Statut:
epublish
Résumé
Household contacts of patients with active pulmonary tuberculosis (TB) often have latent TB infection, and are at risk of progression to disease. We set out to investigate whether index TB case HIV status was linked to a higher probability of latent TB infection among household contacts. Data were collected prospectively from participants in the intervention arm of a household cluster-randomised trial in two South Africa provinces (Mangaung, Free State, and Capricorn, Limpopo). In intervention group households, TB contacts underwent HIV testing and tuberculin skin testing (TST). TST induration was estimated at two cut-offs (≥5mm, ≥10mm). Multilevel Bayesian regression models estimated posterior distributions of the percentage of household contacts with TST induration ≥5mm and ≥10mm by age group, and compared the odds of latent TB infection by key risk factors including HIV status index case age and study province. A total of 2,985 household contacts of 924 index cases were assessed, with most 2,725 (91.3%) undergoing TST. HIV prevalence in household contacts was 14% and 10% in Mangaung and Capricorn respectively. Overall, 16.8% (458/2,725) had TST induration of ≥5mm and 13.1% (359/2,725) ≥10mm. In Mangaung, children aged 0-4 years had a high TST positivity prevalence compared to their peers in Capricorn (22.0% vs. 7.6%, and 20.5% vs. 2.3%, using TST thresholds of ≥5mm and ≥10mm respectively). Compared to contacts from Capricorn, household contacts living in Mangaung were more likely to have TST induration ≥5mm (odds ratio [OR]: 3.08, 95% credibility interval [CI]: 2.13-4.58) and ≥10mm (OR: 4.52, 95% CI: 3.03-6.97). There was a 90% and 92% posterior probability that the odds of TST induration ≥5mm (OR: 0.79, 95% CI: 0.56-1.14) and ≥10mm (OR: 0.77, 95% CI: 0.53-1.10) respectively were lower in household contacts of HIV-positive compared to HIV-negative index cases. High TST induration positivity, especially among young children and people living in Mangaung indicates considerable TB transmission despite high antiretroviral therapy coverage. Household contact of HIV-positive index TB cases were less likely to have evidence of latent TB infection than contacts of HIV-negative index cases.
Identifiants
pubmed: 32182274
doi: 10.1371/journal.pone.0230376
pii: PONE-D-19-29656
pmc: PMC7077873
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0230376Subventions
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT089673
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist
Références
Int J Tuberc Lung Dis. 2010 Apr;14(4):406-12
pubmed: 20202297
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
Lancet. 2015 Dec 5;386(10010):2344-53
pubmed: 26515679
N Engl J Med. 1975 Sep 4;293(10):501-2
pubmed: 1152865
PLoS One. 2014 Apr 23;9(4):e95372
pubmed: 24759741
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000171
pubmed: 20091503
Eur Respir J. 2005 Jan;25(1):181-5
pubmed: 15640340
Lancet Infect Dis. 2016 Feb;16(2):227-38
pubmed: 26867464
Lancet Glob Health. 2017 Nov;5(11):e1048-e1049
pubmed: 29025618
Int J Tuberc Lung Dis. 2015 Nov;19(11):1290-2
pubmed: 26467579
Eur Respir J. 2010 Oct;36(4):925-49
pubmed: 20889463
Eur Respir J. 2013 Jan;41(1):140-56
pubmed: 22936710
Am J Epidemiol. 2017 Jun 15;185(12):1327-1339
pubmed: 28982226
Lancet. 2013 Oct 5;382(9899):1183-94
pubmed: 23915882
PLoS Med. 2019 Apr 23;16(4):e1002787
pubmed: 31013273
N Engl J Med. 2015 May 28;372(22):2127-35
pubmed: 26017823
Lancet Respir Med. 2019 Jun;7(6):544-552
pubmed: 31078497
Cochrane Database Syst Rev. 2017 Aug 29;8:CD006418
pubmed: 28850172
BMC Infect Dis. 2019 Oct 12;19(1):839
pubmed: 31606032
Science. 2013 Feb 22;339(6122):961-5
pubmed: 23430655
Cochrane Database Syst Rev. 2000;(2):CD001363
pubmed: 10796642
Lancet. 2010 May 22;375(9728):1814-29
pubmed: 20488524
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1147-1154
pubmed: 29037295
Bull World Health Organ. 2019 Jun 1;97(6):405-414
pubmed: 31210678